Tgen, Dell Partner To Combine Genomics With Cloud Computing For Personalized Medicine
This article was originally published in The Gray Sheet
Two trials testing Tgen’s approach to using genomics algorithms to help select cancer treatments are ongoing. The further ambition is to unite outcomes data in electronic health records and genomics data to get an even more personalized view of what’s going on with a patient.
You may also be interested in...
A recent study supports a role for genetic testing as a means of personalizing antiplatelet therapy following stent placement and builds the case that newer drugs, such as Eli Lilly/Daiichi Sankyo's Effient (prasugrel), are more appropriate options for those who have poor response to standard Plavix (clopidogrel) treatment.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.